25 March, 2021, 16:00 CET / 15:00 GMT
Dr Filippo Fraggetta shares his experience and clinical results of using INIFY Prostate Screening in the fully digitalized workflow at Cannizzaro hospital, Catania, Italy. INIFY is an AI-based, CE-marked decision support tool. It identifies and outline cancer areas in digitalised prostate biopsy samples and is seamlessly integrated with the hospital’s LIS system. Dr Fraggetta will present clinical results and talk about how bringing AI into the laboratory workflow can benefit both the pathologist and patient. The webinar will begin with an introduction to the philosophy behind the product by Lena Kajland Wilén at ContextVision.
Learning Objectives:
During this webinar you will learn about ContextVision’s CE-marked, decisions support tool - INIFY Prostate Screening - features & benefits
Performance and user experience in routine clinical practice
How AI based decision support tools can be implemented for primary diagnosis
Newsletters
Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.
